Republicans

Republicans Holding Up Emergency Coronavirus Spending To Protect Drug Company Price Gouging
Meeting between White House Coronavirus Task Force and pharmaceutical executives in the Cabinet Room of the White House, March 2, 2020. Image from: Getty Images

Republicans Holding Up Emergency Coronavirus Spending To Protect Drug Company Price Gouging

The Congress is working toward a $7.5 billion emergency spending package for the COVID-19 response, but there's a hurdle: Republicans who don't like language in it that would keep drug companies from price gouging on vaccines and treatments.